Creatine kinase BB in cerebrospinal fluid and blood: methodology and possible clinical application

References

• Wevers R A, Mul-Steinbusch M WFJ, Soons J BJ. Mitochondrial CK (EC 2.7.3.2) in the human heart. Clin Chim Acta 1980; 101: 103–11
   PubMed Web of Science ®Google Scholar
• Gerhardt W, Waldenstrøm J, Hørder M, Hofvendahl S, Billstrøm R, Ljungdahl L, Berning H, Bagger P. Creatine kinase and creatine kinase B-subunit activity in serum in cases of suspected myocardial infarction. Clin Chem 1982; 28: 277–83
   PubMed Web of Science ®Google Scholar
• Zatz M. Diagnosis, carrier detection and genetic counselling in the muscular dystrophies. Ped Clin NA 1978; 25: 557–73
   PubMedGoogle Scholar
• Urdal P, Strømme J H. Effects of Ca, Mg and EDTA on creatine kinase activity in cerebrospinal fluid. Clin Chem 1979; 25: 147–50
   PubMedGoogle Scholar
• Tarkkanen P, Komor S, Cornely C, Hacke W, Greiling H. Biolumínescence assay of creatine kinase and its isoenzymes in serum and cerebrospinal fluid. Clin Chem 1979; 25: 1644–8
   PubMed Web of Science ®Google Scholar
• Zweig M H, Van Steirteghem A C, Schechter A N. Radioimmunoassay of creatine kinase isoenzymes in human serum: Isoenzyme BB. Clin Chem 1978; 24: 422–8
   PubMed Web of Science ®Google Scholar
• Thompson R J, Graham J G, McQueen I NF, Kynock P AM, Brown K W. Radioimmunoassay of brain-type creatine kinase-BB isoenzyme in human tissues and in serum of patients with neurological disorders. J Neurolog Sci 1980; 47: 241–54
   PubMed Web of Science ®Google Scholar
• Urdal P, Kierulf P. Sensitive and specific radioimmunoassay for creatine kinase BB isoenzyme in serum, with use of an auto-antibody. Clin Chem 1981; 27: 83–7
   PubMedGoogle Scholar
• Cooper P R, Chalif D, Ramsey J F, Moore R J. Radioimmunoassay of the brain type isoenzyme of creatine phosphokinase (CK-BB): a new diagnostic tool in the evaluation of patients with head injury. Neurosurgery 1983; 12: 536–41
   PubMedGoogle Scholar
• Jackson A P, Siddle K, Thompson R J. Two-site monoclonal antibody assays for human heart- and brain-type creatine kinase. Clin Chem 1984; 30: 1157–62
   PubMedGoogle Scholar
• Phillips J P, Jones H M, Hitchcock R, Adams N, Thompson R J. Radioimmunoassay of serum creatine kinase BB as index of brain damage after head injury. Br Med J 1980; 281: 777–9
   PubMed Web of Science ®Google Scholar
• Bakay R AE, Ward A A. Enzymatic changes in serum and cerebrospinal fluid in neurological injury. J Neurosurg 1983; 58: 27–37
   PubMedGoogle Scholar
• Nordby H K, Urdal P. The diagnostic value of measuring creatine kinase BB activity in cerebrospinal fluid following acute head injury. Acta Neurochir 1982; 65: 93–101
   PubMed Web of Science ®Google Scholar
• Nordby H K, Urdal P., Bjørnæs H. The prognosis of patients with concussion and increased creatine kinase BB in the cerebrospinal fluid. Acta Neurochir 1984; 71: 205–15
   PubMedGoogle Scholar
• Nordby H K, Urdal P. Creatine kinase BB in blood as an index of prognosis and effect of treatment after severe head injury. Acta Neurochir 1985; 76: 131–6
   PubMedGoogle Scholar
• Kjekshus J K, Vaagenes P, Hetland Ø. Assessment of cerebral injury with spinal fluid creatine kinase (CSF-CK) in patients after cardiac resuscitation. Scand J Clin Lab Invest 1980; 40: 437–44
   PubMed Web of Science ®Google Scholar
• Longstreth W T, Clayson K J, Sumi S M. Cerebrospinal fluid and serum creatine kinase BB activity after out-of-hospital cardiac arrest. Neurology 1981; 31: 455–8
   PubMed Web of Science ®Google Scholar
• Somer H, Konttinen A. Demonstration of serum creatine kinase isoenzymes by fluorescence technique. Clin Chim Acta 1972; 40: 133–8
   PubMed Web of Science ®Google Scholar
• Mercer D W. Separation of tissue and serum creatine kinase isoenzymes by ion-exchange column chromatography. Clin Chem 1974; 20: 36–40
   PubMed Web of Science ®Google Scholar
• Bell R D, Rosenberg R N, Ting R, Mukherjee A, Stone M J, Willerson J T. Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease. Ann Neurol 1978; 3: 52–9
   PubMed Web of Science ®Google Scholar
• Urdal P, Urdal K, Strømme J H. Age-related reference intervals for creatine kinase BB in serum. Scand J Clin Lab Invest 1982; 42: 621–5
   PubMed Web of Science ®Google Scholar
• Kaste M, Somer H, Konttinen A. Heart type creatine kinase isoenzyme (CK-MB) in acute cerebral disorders. Br Heart J 1978; 40: 802–5
   PubMedGoogle Scholar
• Urdal P, Landaas S. Macro creatine kinase BB and some data on its prevalence. Clin Chem 1979; 25: 461–5
   PubMed Web of Science ®Google Scholar
• Jockers-Wretou E, Pfleiderer G. Quantitation of creatine kinase isoenzymes in human tissues and sera by an immunological method. Clin Chim Acta 1975; 58: 223–32
   PubMed Web of Science ®Google Scholar
• Urdal P, Urdal K, Strømme J H. Cytoplasmic creatine kinase isoenzymes quantitated in tissue specimens obtained at surgery. Clin Chem 1983; 29: 310–3
   PubMed Web of Science ®Google Scholar
• Thompson R J, Kynoch P AM, Sarjant J. Immunohistochemical localization of creatine kinase-BB isoenzyme to astrocytes in human brain. Brain Research 1980; 201: 423–6
   PubMed Web of Science ®Google Scholar
• Tsung S H. Several conditions causing elevation of serum CK-MB and CK-BB. Am J Clin Pathol 1981; 75: 711–5
   PubMed Web of Science ®Google Scholar
• Coolen R B, Pragay D A, Nosanchuk J S, Belding R. Elevation of brain-type creatine kinase in serum from patients with carcinoma. Cancer 1979; 44: 1414–18
   PubMed Web of Science ®Google Scholar
• Massay T H, Goe M R. Transient creatine kinase-BB activity in serum or plasma after cardiac or respiratory arrest. Clin Chem 1984; 30: 50–5
   PubMedGoogle Scholar
• Rubery E D, Doran J F, Thompson R J. Brain-type creatine kinase BB as a potential tumour marker: serum levels measured by radioimmunoassay in 1015 patients with histoiogically confirmed malignancies. Eur J Cancer Clin Oncol 1982; 18: 951–6
   PubMedGoogle Scholar
• Thompson R J, Rubery E D, Jones H M. Radioimmunoassay of serum creatine kinase-BB as a tumour marker in breast cancer. Lancet 1980; ii: 673–5
   Google Scholar
• Silverman L M, Dermer G B, Zweig M H, Van Steirteghem A C, Tøkes Z A. Creatine kinase BB: A new tumor-associated marker. Clin Chem 1979; 25: 1432–5
   PubMed Web of Science ®Google Scholar
• Fair W R, Heston W DW, Kadmon D, Crane D B, Catalona W J, Ladenson J H, McDonald J M, Noll B W, Harvey G. Pro-static cancer, acid phosphatase, creatine kinase-BB and race: a prospective study. J Urol 1982; 128: 735–8
   PubMedGoogle Scholar